• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    Albany Molecular Research Inc. (AMRI)

    -NasdaqGS
    17.77 Up 0.57(3.31%) Mar 5, 4:00PM EST
    Add to Portfolio
    Prev Close:17.20
    Open:17.34
    Bid:N/A
    Ask:18.88 x 200
    1y Target Est:20.50
    Beta:1.29
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:17.24 - 17.99
    52wk Range:13.73 - 23.95
    Volume:400,520
    Avg Vol (3m):545,150
    Market Cap:551.15M
    P/E (ttm):N/A
    EPS (ttm):-0.10
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AMRI

    Comparison

    Symbol% ChgMkt Cap
    AMRIUp 3.31%551.15M
    CVD 0.00%N/A
    QUp 1.19%8.17B

    Key Statistics

    Forward P/E (1 yr):18.51
    P/S (ttm):1.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.82
    Quarterly EPS Est (Mar-15) :0.15
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback